Home 5 Clinical Diagnostics Insider 5 The Diagnostics Pipeline: FDA Issues Groundbreaking Clearance for an RSV Vaccine

The Diagnostics Pipeline: FDA Issues Groundbreaking Clearance for an RSV Vaccine

by | May 31, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article